82
30
Growth Score
-4 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2682262
Galepharm AG holds marketing rights for niche prescription therapeutics, including specialized medications like Dexamethasone.
About the Company
Galepharm AG specializes in the marketing authorization of prescription-only niche therapeutics. With a focus on providing unique pharmaceutical solutions, the company holds the marketing rights for various specialized medications, including Dexamethasone Galepharm, an oral corticosteroid available in different dosage strengths and pack sizes.
Galepharm AG serves as a crucial partner for healthcare providers and patients in need of specific therapeutic options not widely available in the market. The company's portfolio addresses a range of medical needs, ensuring accessibility to essential medications.
